Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001398432-18-000103
Filing Date
2018-08-17
Accepted
2018-08-17 16:05:49
Documents
71
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a14261.htm 10-Q 324826
2 SECTION 302 CERTIFICATION EXHIBIT exh31_1.htm EX-31.1 10072
3 SECTION 906 CERTIFICATION EXHIBIT exh32_1.htm EX-32.1 3226
  Complete submission text file 0001398432-18-000103.txt   4444698

Data Files

Seq Description Document Type Size
4 nphc-20180630.xml EX-101.INS 632370
5 nphc-20180630.xsd EX-101.SCH 72355
6 nphc-20180630_cal.xml EX-101.CAL 28655
7 nphc-20180630_def.xml EX-101.DEF 302270
8 nphc-20180630_lab.xml EX-101.LAB 365820
9 nphc-20180630_pre.xml EX-101.PRE 311391
Mailing Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071
Business Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071 (954) 509-0911
NUTRA PHARMA CORP (Filer) CIK: 0001119643 (see all company filings)

EIN.: 912021600 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32141 | Film No.: 181025829
SIC: 2833 Medicinal Chemicals & Botanical Products